We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Shortwave Life Sciences Plc | AQSE:PSY | Aquis Stock Exchange | Ordinary Share | GB00BL6CJQ54 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.45 | 0.00 | 06:52:54 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 0.30 | 0.60 | 0.45 | 0.45 | 0.45 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | 0 | 0.45 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 31/10/2024 | 17:39 | UK RNS | Shortwave Life Sciences Plc YEAR ENDED 30 APRIL 2024 AND DIRECTOR.. |
| 19/9/2024 | 13:30 | ALNC |  IN BRIEF: Shortwave Life Sciences reports "positive" drug safety results |
| 19/9/2024 | 06:00 | UK RNS | Shortwave Life Sciences Plc Positive Pre-Clinical Result Drive to Human.. |
| 31/7/2024 | 11:05 | UK RNS | Shortwave Life Sciences Plc Total Voting Rights |
| 17/7/2024 | 16:20 | UK RNS | Shortwave Life Sciences Plc TR1: Notification of Major Holdings |
| 08/7/2024 | 18:12 | ALNC | IN BRIEF: Shortwave Life Sciences says patent claim gets endorsement |
| 08/7/2024 | 06:00 | UK RNS | Shortwave Life Sciences Plc Company’s Patent Claims Confirmed |
| 03/7/2024 | 14:49 | UK RNS | Shortwave Life Sciences Plc Holding(s) in Company |
| 12/6/2024 | 14:00 | UK RNS | Shortwave Life Sciences Plc Holding(s) in Company |
| 06/6/2024 | 06:00 | UK RNS | Shortwave Life Sciences Plc Name Change Rebranding and Share Option Update |
Shortwave Life Sciences (PSY) Share Charts1 Year Shortwave Life Sciences Chart |
|
1 Month Shortwave Life Sciences Chart |
Intraday Shortwave Life Sciences Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 18/1/2024 | 16:42 | Psych Capital: Psychedelic Healthcare Incubation-Investment Company | - |
| 23/11/2007 | 11:14 | Behavioural Psychologist advice needed urgently | 10 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 18/1/2024 16:42 by hedgehog 100 Current share price 18th. January 2024: 2.95p361,203,467 shares in issue Market capitalisation: £10.6555M. "Psych Capital identifies, funds and builds UK and European companies in psychedelic healthcare. Our mission is to support a new wave of innovators who challenge the status-quo and revolutionise how society deals with mental health conditions." "Psych Capital Plc is an incubation and investment firm focused on the emerging psychedelic science and healthcare industry. Part of its portfolio is its wholly-owned “PSYCH”: a data, insights and networking platform for the psychedelic science and healthcare industry. It has quickly become the industry’s leading resource – powered by trustworthy data, independent analysis and engaging events that attract a highly influential audience of policy makers, scientists and investors." 09 Jun 22, 07:00 Psych Capital PLC - Admission to trading on AQSE "Admission to trading on AQSE Psych Capital Plc, the psychedelic healthcare incubation and investment company, that operates the leading industry data, insights, and networking platform, PSYCH, with over 20,000+ subscribers and over 3,000 delegates to previous events, is pleased to announce that admission of its shares to trading on the Aquis Stock Exchange Growth Market ("AQSE Growth Market") will commence at 8.00a.m. today under the TIDM "PSY" and the ISIN number GB00BL6CJQ54. The Company's Admission Document is available at the Company's website: hxxps://psych.capita Key Highlights · The Company currently has exposure to key segments of the medical psychedelic sector through strategic acquisitions and investments, including: · Clinical research in connection with the development of psychedelic medicines used to treat addiction; · Data collection in relation to developments in the psychedelic sector (including, the legal framework, commerce and science); and · Media and communications platform for the medical psychedelic industry · The Company intends to identify, fund and support the building of future companies across three core pillars: therapeutic treatments, drug development, and data/artificial intelligence · The Company will leverage its portfolio of brands, and network of experts, to identify early-stage opportunities in the medical psychedelic industry · The Psych Platform is a global B2B resource for networking, intelligence, and insights, servicing the industry through publications, newsletters and engaging events · PSYCH Symposium events generate strong revenue through sponsorship and ticket sales. Compelling Investment Proposition Psych Capital is a publicly listed incubation and investment firm that deploys early stage capital whilst building or supporting new companies in Europe's psychedelic science and healthcare industry. PSYCH is a data and intelligence platform for the psychedelic science and healthcare industry. It has quickly become the industry's leading resource - powered by trustworthy data, independent analysis and engaging events that attract a highly influential audience of policy makers, scientists and investors. Market Opportunity The nascent psychedelics' space is quickly being harnessed by a growing base of institutional investors seeking to establish and scale businesses in a landscape showing scientific and commercial promise. · Psych's offering aims to capitalise on the following market dynamics: · Numerous companies are currently creating training plans for psychedelic therapists, including the MIND Foundation and COMPASS Pathway; · The United Nations (UN) Convention on Psychotropic Substances framework for the international control of psychotropic substances lists: Psilocybin, MDMA, DMT and LSD as Schedule I substances, the category indicating the least harm with medical application; · Ketamine is on the WHO list of essential medicines; · Psilocybin therapy is expected to be a key driver in societal education and a contributor to wider reforms across America; · MDMA-assisted therapy can take a strong market share from 2024; · Capital invested in psychedelic companies is over US$2 billion; and · The current value of medical businesses surpasses US$10 billion. For example, ATAI Life Sciences' initial public offering (IPO) last year made it the most valuable publicly-traded business in the sector, currently valued at US$595 million. Placing The Company has raised gross proceeds of £810k from the issue and allotment of 16,200,000 Placing Shares. The Company intends to apply the net proceeds raised from the fundraising activities to support its general working capital requirements and to develop its existing business, whilst certain funds may be applied to enable the Company to make further acquisitions. Total voting rights Following Admission, the total number of Ordinary Shares in issue will be 290,033,335 each with equal voting rights. The Company does not hold any rights in treasury. The total voting rights figure can be used by Shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change of their interest in, the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority. William Potts, Chief Investment Officer and Co-Founder of Psych Capital, commented: "We're the first pure play Psychedelic company to list on a UK stock market at an inflection point for the industry as global interest moves towards the UK due to the leading science and companies here. We believe our IPO is a milestone for the whole psychedelic industry in the UK. "With an escalating global mental health crisis, there's a significant opportunity for innovation to cater to unmet needs and improve patient outcomes worldwide. Encouraged by breakthrough trials and science of psychedelic-assisted therapy, our mission is to support a new wave of innovators who are well positioned to challenge the status-quo and revolutionise how society deals with mental health conditions." ..." N.B. The £810K. (gross) was raised at an issue price of 5p/share. |
Posted at 11/4/2002 19:40 by moonblue The VOD board looks to be increasingly taken over by day traders,you can tell be the surge in the number of messages, that's what happened to Balty just before its price collapsed to near nothing.So here are ten hot tips for you day traders:- (1) Speed is important. Try to trade the entire Techmark index before lunch. (2) Consider alternative financing. Don't overlook the children's pocket money, golf club funds, credit cards, loan sharks and crime as ready sources of investing cash. (3) Place dangerous implements well out of reach. Especially firearms! (4) Good information can come from anywhere. A chat-room tip from a stranger -- ESPECIALLY WHEN IT'S IN ALL CAPITAL LETTERS AND FOLLOWED BY FOUR EXCLAMATION POINTS -- CAN BE WORTH MILLIONS!!!!!!!! (5)Diversify your holdings. Put your life savings in another stock every five minutes. Take out a second mortgage and invest it. You'll pay off the first one quicker that way. (6) Don't tell anyone that you're day trading. Especially your wife. (7) Don't neglect personal hygiene. Take a bath at least once a month - twice if you're trading Geo. (8) Don't forget to have fun. Hit the Bulletin Boards and post "Let's short this *#$*!% stock" on all the day's big gainers. (9) Be daring. Bankruptcy is a learning, growing, character forming experience. (10) Plan well ahead. But rapidly discard all plans if you see another great risk opportunity looming. Good Luck |
Posted at 10/12/2001 08:30 by theblackmamba equities - swing trading ie 0-8 daysexperience 5 years, 3 of which have detailed trade(2480 trades) analysys. rule 1 - do your homework thoroughly. each night i go through 1000 charts coming up with a buy/short shortlist. i put them in my share watchlist, then don't look at the charts again during next trading day. if they reach target price you buy/short rule 2 - keep losses small. people say you should aim to lose 2-3 percent of your pot per tarde. to me that is way to high. if you have 6 losers in a row thats 18percent lost. i try to keep the loss under the average loss of losses over three years. this means each loss is under 0.1 percenmt of pot. can't go bust this way, but also can't get rich quicklly either. rule 3 - have confidence in yourself. i know it sounds arrogant, but i have charts of my performance on the walls, and a screensaver of where i want to live on spare computer in order to motivate me each day. imo you have to believe in yourself coz no one else cares. i must admit, im stoppimg reading btrading threds etc, as there are too many opinions. the only one that matters in the end is yours. you decide to buy, so you mjust choose your poiint of get in, and you must choosev and do your stoplooss. |
Posted at 09/12/2001 20:24 by dead cat bounce Long term members of this BB will probably recall many threads about how people trade. I am still facing problems attaining the discipline needed to successfully trade index futures and I was trying to formulate some simple rules that would be easy to remember and more to the point, easy to keep.Here is a first draft. What do others think? Rule 1. Only enter low risk trades What does this mean? It means only entering a trade when there is overwhelming reason to believe the price will go in the direction you predict. Whatever method of trade entry you use, it has to be solidly behind the trade. No wishing and hoping, no half completed patterns, no breakouts on low volume, no trades against the trend, just solid evidence. It also means that the trade should yield 3:1 risk/reward ratio. This ratio is defined from where you would put your stop. And the stop MUST be placed in a logical place ie, just below solid support if the trade is long, above solid resistance if the trade is short. This means that the trade entry must be sufficiently close to the stop to allow the target exit price to be 3 times further away from your entry than the stop level is. If these figures don't work out, then you don't take the trade. Rule 2. Rigidly stick to your stoploss. Self explanatory really. But how often, when you have had only a mental stop and it has been breached, have you then let it go just that bit further in the hope the trade will come back in your favour? And the manageable loss has turned in to a big hurting loss. Don't let it happen. Rule 3. Stop trading at maximum daily loss. This means setting a maximum daily amount you are prepared to lose (2% of trading capital is recommended). If you lose this amount YOU STOP TRADING FOR THE DAY, no matter what. (Acnowledgements to Mr Potatohead for rule 3) Now I know that there can be many trading rules, but in the heat of daytrading, you need to keep things as simple as possible so that as few things as possible can go wrong. I ask others to write their own rules, maximum of 3 in order to keep it simple and memorable, to help maintain the required discipline while trading. Lets see what we can distill as the 3 rules of successful trading. Some rules will be better suited to equity trading so state which your rules apply to when posting them. dcb |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
